Furthermore, in a recent meta-analysis of six neoadjuvant chemotherapy trials, higher sTIL scores were associated with a significant reduction in OS in luminal BCs, while an increase in the sTIL score was associated with longer DFS in TN and HER2+ BC [11]. Here, ERBB2 is linked to breast cancer.